166 related articles for article (PubMed ID: 32805233)
81. The role of S100A4 for bone metastasis in prostate cancer cells.
Kim B; Jung S; Kim H; Kwon JO; Song MK; Kim MK; Kim HJ; Kim HH
BMC Cancer; 2021 Feb; 21(1):137. PubMed ID: 33549040
[TBL] [Abstract][Full Text] [Related]
82. Structural determinants governing S100A4-induced isoform-selective disassembly of nonmuscle myosin II filaments.
Kiss B; Kalmár L; Nyitray L; Pál G
FEBS J; 2016 Jun; 283(11):2164-80. PubMed ID: 27029887
[TBL] [Abstract][Full Text] [Related]
83. S100A4 expression is closely linked to genesis and progression of glioma by regulating proliferation, apoptosis, migration and invasion.
Jin T; Zhang Z; Yang XF; Luo JS
Asian Pac J Cancer Prev; 2015; 16(7):2883-7. PubMed ID: 25854377
[TBL] [Abstract][Full Text] [Related]
84. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
Ping H; Guo L; Xi J; Wang D
Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
[TBL] [Abstract][Full Text] [Related]
85. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
[TBL] [Abstract][Full Text] [Related]
86. SOX2 expression associates with stem cell state in human ovarian carcinoma.
Bareiss PM; Paczulla A; Wang H; Schairer R; Wiehr S; Kohlhofer U; Rothfuss OC; Fischer A; Perner S; Staebler A; Wallwiener D; Fend F; Fehm T; Pichler B; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C
Cancer Res; 2013 Sep; 73(17):5544-55. PubMed ID: 23867475
[TBL] [Abstract][Full Text] [Related]
87. CD40 ligand induces RIP1-dependent, necroptosis-like cell death in low-grade serous but not serous borderline ovarian tumor cells.
Qiu X; Klausen C; Cheng JC; Leung PC
Cell Death Dis; 2015 Aug; 6(8):e1864. PubMed ID: 26313915
[TBL] [Abstract][Full Text] [Related]
88. Evaluation of potential interactions between the metastasis-associated protein S100A4 and the tumor suppressor protein p53.
Berge G; Mælandsmo GM
Amino Acids; 2011 Oct; 41(4):863-73. PubMed ID: 20177948
[TBL] [Abstract][Full Text] [Related]
89. An immunohistochemical comparison of P53 and Bcl-2 as apoptotic and MIB1 as proliferative markers in low-grade and high-grade ovarian serous carcinomas.
Mishra SK; Crasta JA
Int J Gynecol Cancer; 2010 May; 20(4):537-41. PubMed ID: 20442586
[TBL] [Abstract][Full Text] [Related]
90. Binding to intracellular targets of the metastasis-inducing protein, S100A4 (p9Ka).
Chen H; Fernig DG; Rudland PS; Sparks A; Wilkinson MC; Barraclough R
Biochem Biophys Res Commun; 2001 Sep; 286(5):1212-7. PubMed ID: 11527429
[TBL] [Abstract][Full Text] [Related]
91. Hyperthermia inhibits cell proliferation and induces apoptosis: relative signaling status of P53, S100A4, and Notch in heat sensitive and resistant cell lines.
Basile A; Biziato D; Sherbet GV; Comi P; Cajone F
J Cell Biochem; 2008 Jan; 103(1):212-20. PubMed ID: 17497677
[TBL] [Abstract][Full Text] [Related]
92. Dishevelled family proteins in serous ovarian carcinomas: a clinicopathologic and molecular study.
Karin-Kujundzic V; Kardum V; Sola IM; Paic F; Skrtic A; Skenderi F; Serman A; Nikuseva-Martic T; Vranic S; Serman L
APMIS; 2020 Mar; 128(3):201-210. PubMed ID: 31755579
[TBL] [Abstract][Full Text] [Related]
93. Prognostic impact of concomitant p53 and PTEN on outcome in early stage (FIGO I-II) epithelial ovarian cancer.
Skírnisdóttir I; Seidal T
Int J Gynecol Cancer; 2011 Aug; 21(6):1024-31. PubMed ID: 21792012
[TBL] [Abstract][Full Text] [Related]
94. S100A4 suppresses cancer stem cell proliferation via interaction with the IKK/NF-κB signaling pathway.
Zhu Y; Zhou Y; Zhou X; Guo Y; Huang D; Zhang J; Wang C; Cai L
BMC Cancer; 2018 Jul; 18(1):763. PubMed ID: 30045697
[TBL] [Abstract][Full Text] [Related]
95.
Na K; Sung JY; Kim HS
Anticancer Res; 2017 Dec; 37(12):6697-6703. PubMed ID: 29187446
[TBL] [Abstract][Full Text] [Related]
96. Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.
Barger CJ; Zhang W; Hillman J; Stablewski AB; Higgins MJ; Vanderhyden BC; Odunsi K; Karpf AR
Oncotarget; 2015 Sep; 6(29):27613-27. PubMed ID: 26243836
[TBL] [Abstract][Full Text] [Related]
97. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
[No Abstract] [Full Text] [Related]
98. S100A4 influences cancer stem cell-like properties of MGC803 gastric cancer cells by regulating GDF15 expression.
Guo J; Bian Y; Wang Y; Chen L; Yu A; Sun X
Int J Oncol; 2016 Aug; 49(2):559-68. PubMed ID: 27278086
[TBL] [Abstract][Full Text] [Related]
99. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
[TBL] [Abstract][Full Text] [Related]
100. S100A4 interacts with mutant p53 and affects gastric cancer MKN1 cell autophagy and differentiation.
Shen W; Chen D; Liu S; Chen L; Yu A; Fu H; Sun X
Int J Oncol; 2015 Dec; 47(6):2123-30. PubMed ID: 26497012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
